In this episode of The Mel Robbins Podcast, Dr. Rachel Rubin discusses women's hormonal health and its impact on sexual wellness, bladder function, and quality of life. She explains how hormones fluctuate throughout different life stages and emphasizes the importance of maintaining proper hormonal balance, particularly in addressing conditions like UTIs and vaginal health issues.
The conversation also explores the current state of women's healthcare, including misconceptions about vaginal hormone therapy and gaps in medical education. Dr. Rubin highlights how many healthcare providers lack adequate training in sexual medicine and hormone therapy, leading to potential misdiagnosis and treatment issues. She addresses common concerns about hormone therapy safety and explains recent FDA updates that affect treatment options.

Sign up for Shortform to access the whole episode summary along with additional materials like counterarguments and context.
Rachel Rubin and Dr. Rachel Rubin discuss how hormonal balance significantly impacts women's health. Dr. Rubin explains that hormonal changes can affect multiple aspects of women's health, including bladder function, sexual health, and overall quality of life. She details how GSM (genitourinary syndrome of menopause) influences the vagina, vulva, bladder, and urethra during hormonal shifts.
According to Dr. Rubin, hormones fluctuate throughout different life stages, including puberty, pregnancy, breastfeeding, perimenopause, and menopause. Rather than viewing hormones as "good" or "bad," she emphasizes the importance of maintaining proper hormonal balance for optimal health.
Hormonal fluctuations can significantly impact women's health, particularly regarding UTIs and vaginal health. Dr. Rubin explains that changes in hormones can alter the vaginal microbiome and pH balance, leading to various symptoms including dryness, irritation, and painful sex. These changes can occur due to various factors, including birth control pills, breastfeeding, and menopause.
Dr. Rubin advocates for the broader use of vaginal hormone therapy, highlighting its safety and effectiveness in treating conditions like UTIs and sexual dysfunction. She explains that these treatments work locally and don't carry the same risks as systemic hormone therapy. A significant development occurred in 2026 when the FDA removed misleading warning labels from vaginal hormone therapy products, which had previously suggested incorrect risks of serious health conditions.
Dr. Rubin reveals a concerning gap in medical education regarding women's sexual and hormonal health. She points out that gynecologists primarily receive training in reproductive health rather than sexual medicine, and many healthcare providers lack proper education about prescribing vaginal hormone therapy. This knowledge gap often results in misdiagnosis and inadequate treatment of women's health issues. As of 2026, medical curricula for gynecologists still don't require learning about crucial aspects of sexual health, highlighting the ongoing need for improved medical education in this area.
1-Page Summary
Hormonal balance is crucial to women's health, affecting various aspects of their well-being, including bladder health, sexual function, and quality of life.
Rachel Rubin and Dr. Rachel Rubin discuss the wide-ranging impacts of hormones on women's health.
Rubin identifies waking up more at night to urinate, experiencing dry, scratchy, or painful sex, or feeling off as signs of hormonal health issues. Dr. Rubin details GSM (genitourinary syndrome of menopause) which influences the vagina, vulva, bladder, and urethra during hormonal shifts. These hormonal fluctuations, affecting estrogen and [restricted term], can alter vaginal tissue function and pH balance. The growth of bad bacteria, decrease in good bacteria, dryness, thinning tissues, discomfort, and painful sex can occur due to reduced acidity in the vagina caused by these hormonal changes. Additionally, these changes can result in difficulties with arousal and orgasm, diminishment of the labia minora, and urinary discomforts such as UTIs, urgency, and leakage. Robbins questions if her frequent urination could be linked to such changes rather than external factors.
The discussion emphasizes the lack of focus on women's health within medicine, underscoring the need for medical professionals to take women's sexual and urinary health seriously, as these strongly affect their quality of life.
[restricted term] therapy has been shown to provide various benefits, such as mood improvements, better sexual function, and alleviation of stress incontinence, as the urethra possesses [restricted term] receptors. An anecdote is shared about a woman regaining the ability to experience orgasms following [restricted term] treatment, underlining hormones' significant impact on sexual functionality and overall well-being. Increased energy and inner strength resulting from attention to sexual health and quality of life can enhance relationships, work, home life with children, and personal decision-making.
Dr. Rachel Rubin highlights that estrogen, progesterone, and [restricted ...
Hormonal Health and Overall Well-Being
Experts discuss the impact of hormone fluctuations on women's health, with a focus on urinary tract infections (UTIs) and issues related to hormonal imbalance such as vaginal dryness and painful sex.
Mel Robbins and Rachel Rubin bring attention to the relationship between hormonal changes and UTIs. Rubin explains hormonal fluctuations due to various factors like birth control pills, breastfeeding, hormone therapies used in breast cancer treatment, and stages like perimenopause and menopause can drastically increase the risk of UTIs. She emphasizes the significant impact of hormone fluctuations on women's health as they alter the vaginal and bladder microbiome.
Hormonal changes can cause the vaginal tissues to dry and thin, leading to discomfort and painful sex. Rubin discusses symptomatic issues such as urinary frequency, urgency, leakage, UTIs, dryness, and pain that could indicate the need for vaginal hormones. She also notes that birth control pills can induce a low [restricted term] state in women, which can result in vaginal discomfort and sexual issues.
Rubin details how without hormones, the tissue and the acidity changes in the bladder and vagina can lead to a dysbiosis, altering the environment and pH balance, making conditions less favorable to the vaginal microbiome. This imbalance can lead to symptoms like dryness, itchiness, and pain during sex. [restricted term] therapy is mentioned as a treatment that enhances lubrication and reduces discomfort from hormonal imbalances.
Additionally, she elaborates on how the vulvar vestibule, which is sensitive to hormonal changes, can become dry and irritated. Symptoms such as vaginal dryness, irritation, and painful sex are signs of hormonal imbalance that can arise after childbirth, during breastfeeding, and with aging due to a decline in hormones, particularly [restricted term].
Rubin also brings up genit ...
Common Women's Health Issues Related To Hormonal Changes
Expert Dr. Rachel Rubin raises awareness regarding the underutilization and misconceptions of vaginal hormone therapy, advocating for its role in treating conditions like UTIs and sexual dysfunction.
Robbins introduces Rubin as an expert educating doctors on proper hormone prescription. Rubin highlights the safety and effectiveness of vaginal hormone therapy for treating urinary pain, urinary tract infections, and pain with sex. She points out that vaginal hormones, including both estrogen and DHEA, are very effective in preventing UTIs and enhancing sexual health by improving arousal, lubrication, and alleviating painful intercourse. They also address urinary symptoms such as frequency, urgency, and leakage, and have a role in maintaining the vaginal microbiome.
Furthermore, vaginal hormone therapy is a cost-effective method that is often covered by insurance and does not harm the gut lining like repeated antibiotic use might. Rubin discusses that microdosing small amounts of vaginal hormones can prevent and cure conditions such as dryness, thinning of the vagina, and UTIs without the risks associated with systemic hormone therapy. She emphasizes that these treatments offer benefits without any significant increase in systemic estrogen levels and can be a real rejuvenation for the tissue.
Rubin explains that for generations, doctors were not educated on how to prescribe hormone therapies, leading to a lack of access to these treatments. She confronted challenges due to outdated warning labels that caused fear around the use of vaginal hormones, incorrectly suggesting they led to blood clots, strokes, and heart attacks. She had to assert her expertise numerous times against such misconceptions to dispense prescriptions effectively.
In an impactful change championed by advocacy, the FDA officially removed the misleading warning labels from vaginal hormone therapy products on February 12th, 2026. These labels inaccurately claimed these products increased risks of stroke, blood clots, heart attacks, and probable dementia and were unnecessary obstructions to effective treatment. Rubin underscores the significance of this change, which she considers game-changing, indicating that the medicine was always safe and potentially life-saving. The removal of these labels enables clinicians to better educate and prescribe life-improving vaginal hormone therapies without the hindr ...
The Underutilization and Misconceptions Around Vaginal Hormone Therapy
The discussion led by Dr. Rachel Rubin reveals a widespread problem in the medical field: the lack of proper education and training on women's sexual and hormonal health among healthcare providers. Rubin, alongside other speakers like Mel Robbins, voices concerns over the significant implications this knowledge gap has on women's healthcare.
Dr. Rubin points out that gynecologists, often presumed to be experts in all realms of women's sexual health, actually receive training that predominantly covers reproductive health rather than sexual medicine unless they take a particular interest in it. This knowledge gap causes misdiagnosis, symptom dismissal, and inadequate treatments like vaginal hormone therapy.
Rubin mentions that urologists, who could manage genital and sexual health issues for all genders, are perceived mostly in relation to men's sexual health. This specialized training overlooking women's health contributes to a scarcity in the expertise needed in women's sexual medicine and urology. She emphasizes that as of 2026, medical curriculums for gynecologists do not mandate learning about the clitoris or other segments of sexual health.
Medical professionals, including family doctors and gynecologists, often lack education on the prescription and benefits of vaginal hormone therapy, which could help treat urinary tract infections (UTIs) and sexual dysfunction. Rubin is committed to closing this education gap by teaching clinicians on how to prescribe and use previously misconstrued medications correctly, and why they're important.
Rubin's discussion with Mel Robbins highlights the unawareness amongst healthcare providers regarding hormonal treatment options for issues like UTIs and sexual dysfunction. This ignorance is further validated by the revelation that many people are struggling with symptoms that vaginal hormone therapies could alleviate, but these treatments are severely underutilized.
The current training inadequacies create a dire need for empowerment in the field of women's hormonal and sexual health. Rubin points to examples like vaginal DHEA, a hormone therapy that adds both estrogen and [restricted term], critical for tissues yet often neglected due to accessibility issues.
Rubin, who teaches doctors globally on proper diagnosis and treatments of sexual health conditions, describes the frequent invalidation of patients' complaints about sexual health. These are often dismissed or diagnosed incorrectly by doctors untrained in this field. She stresses the importance for patients to educate themselves and collaborate with their doctors, who might not have complete knowledge in certain areas.
Rubin also criticizes th ...
Inadequate Education and Training on Women's Sexual and Hormonal Health Among Healthcare Providers
Download the Shortform Chrome extension for your browser
